Easywell Biomedicals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 36.97 million compared to TWD 35.07 million a year ago. Net loss was TWD 48.71 million compared to TWD 52.18 million a year ago.

Basic loss per share from continuing operations was TWD 0.43 compared to TWD 0.46 a year ago.